KREITZER ANATOL (Chief Discovery Officer) sold 17.2% of their position (36.28K shares) of MAPLIGHT THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.35M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Voting Common Stock
Shares
−5.54K
Price / share
$36.13
Trade value
$200.34K
% of position
Voting Common Stock
Shares
−4.51K
Price / share
$36.94
Trade value
$166.60K
% of position
Voting Common Stock
Shares
−7.46K
Price / share
$36.66
Trade value
$273.63K
% of position
Voting Common Stock
Shares
−1.59K
Price / share
$37.44
Trade value
$59.60K
% of position
Voting Common Stock
Shares
−2.83K
Price / share
$37.05
Trade value
$104.96K
% of position
Voting Common Stock
Shares
−14.14K
Price / share
$37.70
Trade value
$533.08K
% of position
Voting Common Stock
Shares
−200.00
Price / share
$38.39
Trade value
$7.68K
% of position
Net shares
−36.28K
Net value
-$1.35M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Voting Common Stock Direct | 7/15/2026 | S · Sale | −5.54K | $36.13 | $200.34K | 2.6% | 211.19K | 205.65K |
| Voting Common Stock Direct | 7/15/2026 | S · Sale | −4.51K | $36.94 | $166.60K | 2.2% | 205.65K | 201.13K |
| Voting Common Stock Direct | 7/16/2026 | S · Sale | −7.46K | $36.66 | $273.63K | 3.7% | 201.13K | 193.67K |
| Voting Common Stock Direct | 7/16/2026 | S · Sale | −1.59K | $37.44 | $59.60K | 0.8% | 193.67K | 192.08K |
| Voting Common Stock Direct | 7/17/2026 | S · Sale | −2.83K | $37.05 | $104.96K | 1.5% | 192.08K | 189.25K |
| Voting Common Stock Direct | 7/17/2026 | S · Sale | −14.14K | $37.70 | $533.08K | 7.5% | 189.25K | 175.11K |
| Voting Common Stock Direct | 7/17/2026 | S · Sale | −200.00 | $38.39 | $7.68K | 0.1% | 175.11K | 174.91K |
| Total | −36.28K | -$1.35M | ||||||